336 related articles for article (PubMed ID: 32902794)
21. Anti-Angiogenics: Their Value in Colorectal Cancer Therapy.
Seeber A; Gunsilius E; Gastl G; Pircher A
Oncol Res Treat; 2018; 41(4):188-193. PubMed ID: 29562227
[TBL] [Abstract][Full Text] [Related]
22. Development of new drugs in angiogenesis.
Ziche M; Donnini S; Morbidelli L
Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
[TBL] [Abstract][Full Text] [Related]
23. Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system.
Tie J; Desai J
Crit Rev Oncog; 2012; 17(1):51-67. PubMed ID: 22471664
[TBL] [Abstract][Full Text] [Related]
24. The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells.
Wang S; Cai R; Ma J; Liu T; Ke X; Lu H; Fu J
Phytomedicine; 2015 Oct; 22(11):1017-26. PubMed ID: 26407944
[TBL] [Abstract][Full Text] [Related]
25. Vascular disrupting agents in cancer therapy.
Smolarczyk R; Czapla J; Jarosz-Biej M; Czerwinski K; CichoĊ T
Eur J Pharmacol; 2021 Jan; 891():173692. PubMed ID: 33130277
[TBL] [Abstract][Full Text] [Related]
26. Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression.
Goto H; Nishioka Y
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286323
[TBL] [Abstract][Full Text] [Related]
27. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
van Kempen LC; Leenders WP
Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
[TBL] [Abstract][Full Text] [Related]
28. VEGF signaling in cancer treatment.
Sia D; Alsinet C; Newell P; Villanueva A
Curr Pharm Des; 2014; 20(17):2834-42. PubMed ID: 23944367
[TBL] [Abstract][Full Text] [Related]
29. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
30. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review).
Katoh M
Int J Mol Med; 2013 Oct; 32(4):763-7. PubMed ID: 23863927
[TBL] [Abstract][Full Text] [Related]
31. Redundant angiogenic signaling and tumor drug resistance.
Gacche RN; Assaraf YG
Drug Resist Updat; 2018 Jan; 36():47-76. PubMed ID: 29499837
[TBL] [Abstract][Full Text] [Related]
32. Vaccination approach to anti-angiogenic treatment of cancer.
Wentink MQ; Huijbers EJ; de Gruijl TD; Verheul HM; Olsson AK; Griffioen AW
Biochim Biophys Acta; 2015 Apr; 1855(2):155-71. PubMed ID: 25641676
[TBL] [Abstract][Full Text] [Related]
33. VEGF-A splicing: the key to anti-angiogenic therapeutics?
Harper SJ; Bates DO
Nat Rev Cancer; 2008 Nov; 8(11):880-7. PubMed ID: 18923433
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.
Veeravagu A; Hsu AR; Cai W; Hou LC; Tse VC; Chen X
Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):59-71. PubMed ID: 18221053
[TBL] [Abstract][Full Text] [Related]
35. The Role of CC-Chemokines in the Regulation of Angiogenesis.
Ridiandries A; Tan JT; Bursill CA
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834814
[TBL] [Abstract][Full Text] [Related]
36. Tumor angiogenesis and anti-angiogenic therapies.
Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
[TBL] [Abstract][Full Text] [Related]
37. The ensemble of genetic factors and angiogenic signals via VEGF receptors in lung cancer progression.
Danish Q; Mokhdomi TA; Bukhari S; Ahmad R
Cancer Biomark; 2015; 15(5):619-33. PubMed ID: 26406951
[TBL] [Abstract][Full Text] [Related]
38. Targeting Angiogenesis in Biliary Tract Cancers: An Open Option.
Simone V; Brunetti O; Lupo L; Testini M; Maiorano E; Simone M; Longo V; Rolfo C; Peeters M; Scarpa A; Azzariti A; Russo A; Ribatti D; Silvestris N
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212293
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic inhibition of angiogenesis.
Zhang HT; Bicknell R
Mol Biotechnol; 2003 Oct; 25(2):185-200. PubMed ID: 14526126
[TBL] [Abstract][Full Text] [Related]
40. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
